3E09X0MIntroduction of Antineoplastic, Monoclonal Antibody, into Nose, External Approach

Administration›Physiological Systems and Anatomical Regions›Introduction
  • Billable / Specific Code
ICD-10-PCS 3E09X0M
CMS Source: FY 2027 ICD-10-PCS dataset. Effective Oct 1, 2026 – Sep 30, 2027.FacebookXLinkedInPrint

3E09X0M is a billable ICD-10-PCS procedure code for Introduction of Antineoplastic, Monoclonal Antibody, into Nose, External Approach. It is valid on HIPAA claims for fiscal year 2027 (October 1, 2026 through September 30, 2027).

Code Identity

ICD-10-PCS Code
3E09X0M
Billable Status
Yes — Valid for Submission
Code Describes
Introduction of Antineoplastic, Monoclonal Antibody, into Nose, External Approach
Short Description
Introduce of Antneo, Moncln Ab, into Nose, Extern Approach
Parent Code
3E0

PCS Table Breakdown

Each ICD-10-PCS code is built from seven characters, each an axis of the procedure. Hover or tap the icons for the official CMS definitions.

PositionDesignationValueMeaning
1Section3Administration
2Body SystemEPhysiological Systems and Anatomical Regions
3Operation0Introduction
4BodySystem/Region9Nose
5ApproachXExternal
6Substance0Antineoplastic
7QualifierMMonoclonal Antibody

Similar Procedure Codes

Questions About 3E09X0M

Is 3E09X0M a billable code?

Yes. This is a complete seven-character ICD-10-PCS code, specific enough to report Introduction of Antineoplastic, Monoclonal Antibody, into Nose, External Approach on inpatient claims from October 1, 2026 through September 30, 2027.

What do the characters in 3E09X0M mean?

The code breaks down character by character: the 1st character 3 is the Section (Administration); the 2nd character E is the Body System (Physiological Systems and Anatomical Regions); the 3rd character 0 is the Operation (Introduction); the 4th character 9 is the BodySystem/Region (Nose); the 5th character X is the Approach (External); the 6th character 0 is the Substance (Antineoplastic); the 7th character M is the Qualifier (Monoclonal Antibody).